Detalhe da pesquisa
1.
T cell involvement in antiphospholipid syndrome.
Clin Immunol
; 263: 110218, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38640985
2.
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.
Ann Rheum Dis
; 83(1): 15-29, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37827694
3.
Anticoagulant and non-anticoagulant therapy in thrombotic antiphospholipid syndrome: old drugs and new treatment targets.
Rheumatology (Oxford)
; 63(SI): SI96-SI106, 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320592
4.
Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations.
Rheumatology (Oxford)
; 63(SI): SI24-SI36, 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320589
5.
The impact of traditional cardiovascular risk factor control on 7-year follow-up atherosclerosis progression in systemic lupus erythematosus.
Rheumatology (Oxford)
; 63(1): 50-57, 2024 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086440
6.
Arterial stiffness tested by pulse wave velocity and augmentation index for cardiovascular risk stratification in antiphospholipid syndrome.
Rheumatology (Oxford)
; 63(4): 1030-1038, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37294733
7.
7-year follow-up atherosclerotic plaque progression in patients with antiphospholipid syndrome versus diabetes mellitus and healthy controls.
Rheumatology (Oxford)
; 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38321577
8.
Outcomes of COVID-19 Omicron variant in patients with rheumatoid arthritis: a nationwide Greek cohort study.
Rheumatology (Oxford)
; 63(4): 1130-1138, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467059
9.
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry.
Rheumatology (Oxford)
; 63(3): 772-779, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37307082
10.
Identification and characteristics of patients with potential difficult-to-treat Psoriatic Arthritis: exploratory analyses of the Greek PsA registry.
Rheumatology (Oxford)
; 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38759119
11.
Efforts to Better Characterize "Antiphospholipid Antibody Nephropathy" for the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria: Renal Pathology Subcommittee Report.
J Rheumatol
; 51(2): 150-159, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37399462
12.
Progression of subclinical atherosclerosis in ankylosing spondylitis: a 10-year prospective study.
Rheumatol Int
; 44(4): 643-652, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38349401
13.
Outcomes of COVID-19 re-infections: a single-center cohort of 167 patients with systemic rheumatic diseases.
Rheumatol Int
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548908
14.
Glucocorticoid discontinuation rate and risk factors for relapses in a contemporary cohort of patients with giant cell arteritis.
Rheumatol Int
; 44(4): 603-610, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300269
15.
Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study.
Lab Invest
; 103(6): 100147, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37044248
16.
Antiphospholipid syndrome nephropathy: Current knowledge and unanswered questions.
Clin Immunol
; 255: 109735, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37572950
17.
Assessing disease activity and damage in antiphospholipid syndrome.
Clin Immunol
; 255: 109727, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37558149
18.
Augmented oxidative stress, accumulation of DNA damage and impaired DNA repair mechanisms in thrombotic primary antiphospholipid syndrome.
Clin Immunol
; 254: 109693, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37454866
19.
Distinct innate and adaptive immunity phenotypic profile at the circulating single-cell level in Psoriatic Arthritis.
Clin Immunol
; 253: 109679, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37336253
20.
Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome.
J Autoimmun
; 134: 102978, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36587511